LISCure Biosciences Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$14.1M
- Investors
-
18
LISCure Biosciences General Information
Description
Developer of bacteria-mediated immunotherapy designed to treat tumors as well as cancer. The company's immunotherapy is used by combining drugs, consisting of seven pipelines of medicine and two pipelines of health-functioning food, enabling healthcare professionals to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases.
Contact Information
Website
www.liscure.bioCorporate Office
- C-801, 700, Daewangpangyo-ro
- Bundang-gu
- Seongnam, Gyeonggi 13488
- South Korea
Corporate Office
- C-801, 700, Daewangpangyo-ro
- Bundang-gu
- Seongnam, Gyeonggi 13488
- South Korea
LISCure Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 19-Dec-2024 | $14.1M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 14-Nov-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 28-Jul-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 25-Feb-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Oct-2020 | $1.76M | $1.76M | Completed | Generating Revenue | |
| 1. Seed Round | 25-Jul-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LISCure Biosciences Comparisons
Industry
Financing
Details
LISCure Biosciences Competitors (14)
One of LISCure Biosciences’s 14 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Gilead | Formerly VC-backed | Foster City, CA |
LISCure Biosciences Patents
LISCure Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025143685-A1 | Leuconostoc falkenbergense lbmb321010 strain, and composition comprising same for preventing, alleviating or treating degenerative brain diseases | Inactive | 26-Dec-2023 | ||
| WO-2025135871-A1 | Levilactobacillus parabrevis lbmb320041 strain and composition comprising same for preventing, alleviating or treating degenerative brain diseases | Inactive | 20-Dec-2023 | ||
| CA-3223757-A1 | Composition for treatment of autoimmune diseases comprising lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient | Pending | 07-Jul-2021 | ||
| EP-4368193-A1 | Composition for treatment of autoimmune diseases comprising lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient | Pending | 07-Jul-2021 | ||
| EP-4368193-A4 | Composition for treatment of autoimmune diseases comprising lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient | Pending | 07-Jul-2021 | A61K35/747 |
LISCure Biosciences Signals
LISCure Biosciences Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DT & Investment | Corporate Venture Capital | Minority | ||
| Easy Asset Management | Corporation | Minority | ||
| IBK Securities | Limited Partner | Minority | ||
| InterValue Partners | Venture Capital | Minority | ||
| Roy Investment Partners | PE/Buyout | Minority |
LISCure Biosciences FAQs
-
When was LISCure Biosciences founded?
LISCure Biosciences was founded in 2018.
-
Where is LISCure Biosciences headquartered?
LISCure Biosciences is headquartered in Seongnam, South Korea.
-
What is the size of LISCure Biosciences?
LISCure Biosciences has 30 total employees.
-
What industry is LISCure Biosciences in?
LISCure Biosciences’s primary industry is Drug Discovery.
-
Is LISCure Biosciences a private or public company?
LISCure Biosciences is a Private company.
-
What is LISCure Biosciences’s current revenue?
The current revenue for LISCure Biosciences is .
-
How much funding has LISCure Biosciences raised over time?
LISCure Biosciences has raised $47.5M.
-
Who are LISCure Biosciences’s investors?
DT & Investment, Easy Asset Management, IBK Securities, InterValue Partners, and Roy Investment Partners are 5 of 18 investors who have invested in LISCure Biosciences.
-
Who are LISCure Biosciences’s competitors?
Vedanta Biosciences, Gesynta Pharma, Cardurion, Bristol-Myers Squibb, and Gilead are some of the 14 competitors of LISCure Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process